CompletedPhase 3

Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients

Spain60 participantsStarted 2013-01

Plain-language summary

Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI\>30 Kg/m2 * Type 2 diabetes mellitus * Treatment with Metformin Exclusion Criteria: * Under insulin treatment * Endocrinological disorders causing diabetes mellitus

What they're measuring

Serum glucose levels (mg/dl)

Timeframe: Baseline and 12 weeks after beginning the therapy

Trial details

NCT IDNCT02122874

SponsorHospital General Universitario Elche

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-04

View on ClinicalTrials.gov More Diabetes Mellitus Type 2 in Obese trials